Postacute coronavirus disease 2019 (COVID-19) syndrome in maxillofacial surgeons after initial infection: A Brazilian experience

• Published in: Infection control and hospital epidemiology Vol. 43; no. 11; pp. 1744 - 1746
• Main Authors: Santana, Lucas Alves da Mota, Lima dos Santos, Marcos Antônio, de Albuquerque, Hélio Igor Melo, de Oliveira, Eduardo Morato, Miguita Luiz, Lucyene, Takeshita, Wilton Mitsunari, Souza, Liane Maciel de Almeida
• Format: Journal Article
• Language: English
• Published: New York, USA Cambridge University Press 01.11.2022
• Subjects: Anxiety; Asymptomatic; Coronaviruses; COVID-19; Dyspnea; Fatigue; Fever; Guillain-Barre syndrome; Headaches; Hospitalization; Hypertension; Insomnia; Letter to the Editor; Pandemics; Quality of life; Severe acute respiratory syndrome coronavirus 2
• ISSN: 0899-823X; 1559-6834
• DOI: 10.1017/ice.2021.401

Age/Sex COVID-19 Test Resultsa COVID-19 Symptoms RT-qPCR Test After First Record Persistent Symptoms After Acute COVID-19 (6 months) Persistent Symptoms After Acute COVID-19 (12 months) 1 47 y/ M Positive Fever, cough, dyspnea, headache, myalgia, anosmia, ageusia, intestinal complications Positive (2 months) Headache and myalgia Headache, fatigue, and hyperglycemia 2 51 y/ F Positive Fever, cough, dyspnea, headache, myalgia, intestinal complications, coryza Negative (1 month) Fatigue and muscle weakness Vertigo, hypertensive crisis, and hormonal disorders 3 52 y/ M Positive Cough, anosmia, hypogeusia, headache, myalgia Negative (1 month) Fatigue, anxiety, memory loss, inability to concentrate, headache, hypogeusia, and anosmia Fatigue, anxiety, and inability to concentrate 4 45 y/ M Positive Fever, cough, anosmia, ageusia, and myalgia Positive (5 months) Fatigue, cough, insomnia, hypogeusia, anosmia, memory loss, inability to concentrate, and hypertension Memory loss, inability to concentrate, and hypertension 5 46 y/ M Positive Cough, anosmia, ageusia Negative (1 month) Fatigue, cough, anosmia, ageusia, muscle weakness Fatigue, muscle weakness, hypertension, glycemic alterations 6 47 y/ M Positive Fever, cough, headache, muscle weakness Positive (4 months) Fatigue, hypogeusia, and anosmia Insomnia, hypogeusia, and anosmia 7 38 y/ M Positive Myalgia, sore throat, intestinal complications Negative (1 month) No No 8 46 y/ M Positive Fever, cough, coryza, dyspnea, anosmia, myalgia, ageusia, headache, muscle weakness, myalgia, intestinal complications Negative (1 month) Fatigue and cough Fatigue 9 53 y/ M Positive Fever, cough, headache, myalgia, anosmia, ageusia, intestinal complications Negative (1 month) Fatigue, cough, joint pain, headache, myalgia, anosmia, and ageusia No 10 46 y/ M Positive Fever, cough, dyspnea, headache, myalgia, anosmia, ageusia Negative (1 month) Fatigue, anxiety, insomnia, memory loss and inability to concentrate, myalgia, headache, hypertension Anxiety, insomnia, myalgia, headache, hypertension, and hair loss 11 42 y/ M Positive Fever, cough, myalgia, anosmia, ageusia Positive (2 months) Fatigue, cough, anxiety, hypogeusia, anosmia, memory loss, and fatigue Cough 12 39 y/ M Positive Anosmia, ageusia Negative (1 month) No No 13 60 y/ M Positive Anosmia, ageusia Negative (1 month) Fatigue, anxiety, and myalgia No 14 45 y/ M Positive Asymptomatic Negative (1 month) No No 15 41 y/ M Positive Asymptomatic Negative (1 month) No No 16 45 y/ M Negative No Negative (1 month) No No 17 56 y/ M Negative No Negative (1 month) No No 18 40 y/ M Negative No Negative (1 month) No No 19 38 y/ M Negative No Negative (1 month) No No 20 44 y/ F Negative No Negative (1 month) No No These postacute symptoms ranged from mild to moderate, including fever, muscle disorders, chemosensory alterations, respiratory and intestinal complications, and intestinal alterations. [...]the continuation of these symptoms beyond 6 months were reported by 9 of the 11 maxillofacial surgeons diagnosed with postacute COVID-19 syndrome. Researchers have focused on the analysis of the sequelae of COVID-19 in hospitalized patients once they are expected to have longer convalescence.5 The professionals evaluated in our study did not need hospitalization; thus, regardless of the severity of the disease, the sequelae may be significant and can impact quality of life.